Follicular fluid sex-steroids, insulin-like growth factor-I (IGF-I), IGF-I binding protein (IGF-I-BP) and epidermal growth factor were investigated in patients with polycystic ovaries and normally ovulating women, following ovulation induction with gonadotrophins or growth hormone plus gonadotrophins. Growth hormone supplementation enhanced the ovarian response to gonadotrophins, and significantly increased follicular fluid IGF-I in both groups, without affecting follicular fluid epidermal growth factor; growth hormone supplementation significantly decreased follicular fluid androstenedione in both groups.

Effects of growth hormone administration in addition to gonadotrophins in normally ovulating women and polycystic ovary syndrome (PCO) patients / Volpe, Annibale; P. G., Artini; A., Barreca; F., Minuto; G., Coukos; A. R., Genazzani. - In: HUMAN REPRODUCTION. - ISSN 0268-1161. - STAMPA. - 7:(1992), pp. 1347-1352. [10.1093/oxfordjournals.humrep.a137571]

Effects of growth hormone administration in addition to gonadotrophins in normally ovulating women and polycystic ovary syndrome (PCO) patients.

VOLPE, Annibale;
1992

Abstract

Follicular fluid sex-steroids, insulin-like growth factor-I (IGF-I), IGF-I binding protein (IGF-I-BP) and epidermal growth factor were investigated in patients with polycystic ovaries and normally ovulating women, following ovulation induction with gonadotrophins or growth hormone plus gonadotrophins. Growth hormone supplementation enhanced the ovarian response to gonadotrophins, and significantly increased follicular fluid IGF-I in both groups, without affecting follicular fluid epidermal growth factor; growth hormone supplementation significantly decreased follicular fluid androstenedione in both groups.
1992
Inglese
7
1347
1352
Adult, Androstenedione; biosynthesis, Carrier Proteins; biosynthesis, Drug Synergism, Epidermal Growth Factor; biosynthesis, Estradiol; biosynthesis, Female, Follicular Fluid; chemistry/drug effects, Gonadotropins; pharmacology, Growth Hormone; pharmacology, Humans, Infertility; Female; drug therapy, Insulin-Like Growth Factor Binding Protein 1, Insulin-Like Growth Factor I; biosynthesis, Ovulation Induction; methods, Ovulation; drug effects, Polycystic Ovary Syndrome; drug therapy, Progesterone; biosynthesis
none
info:eu-repo/semantics/article
Contributo su RIVISTA::Articolo su rivista
262
Effects of growth hormone administration in addition to gonadotrophins in normally ovulating women and polycystic ovary syndrome (PCO) patients / Volpe, Annibale; P. G., Artini; A., Barreca; F., Minuto; G., Coukos; A. R., Genazzani. - In: HUMAN REPRODUCTION. - ISSN 0268-1161. - STAMPA. - 7:(1992), pp. 1347-1352. [10.1093/oxfordjournals.humrep.a137571]
Volpe, Annibale; P. G., Artini; A., Barreca; F., Minuto; G., Coukos; A. R., Genazzani
6
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/741294
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 24
social impact